Skip to main content
. 2017 May 1;8(2):85–96.

Table 2.

Graft survival rates at 1, 3, 5, and 10 years after kidney transplantation among pediatric patients based on different recipient, donor, and transplant characteristics

Variable Graft survival rate (SEM), %
p value
1-year 3-year 5-year 10-year
Recipient age group (yrs) 0.19
3–6 80 (7) 80 (7) 80 (7) 40 (10)
7–10 88 (2) 83 (3) 83 (3) 69 (6)
11–14 96 (1) 81 (4) 76 (5) 76 (5)
15–18 86 (4) 81 (4) 81 (4) 59 (8)
Recipient sex 0.34
Male 85 (3) 77 (3) 77 (3) 64 (6)
Female 94 (2) 87 (3) 85 (3) 62 (6)
Dialysis status before the transplantation 0.006
Pre-emptive transplantation 91 (3) 86 (4) 86 (4) 86 (4)
Hemodialysis 90 (2) 83 (3) 83 (3) 60 (6)
Peritoneal dialysis 84 (8) 67 (11) 67 (11) 33 (14)
Dialysis duration before the transplantation (yrs) 0.003
<1 87 (5) 58 (7) 58 (7) 29 (12)
1–3 91 (3) 86 (4) 86 (4) 75 (6)
>3 88 (6) 88 (6) 88 (6) 53 (11)
Immunosuppressive regimen 0.001
Steroid + CSA + AZA 78 (5) 55 (6) 49 (6) 34 (7)
Steroid + CSA + MMF 94 (2) 89 (3) 89 (3) 76 (7)
Steroid + MMF + TAC 80 (6) 80 (6) 80 (6) NA*
Steroid + MMF + SRL 92 (3) 92 (3) 80 (5) NA
Presence of acute rejection 0.002
Yes 79 (4) 69 (4) 69 (4) 52 (7)
No 93 (1) 87 (2) 85 (2) 66 (4)
Donor type 0.002
Living related 100 (0) 100 (0) 100 (0) 100 (0)
Living unrelated 88 (2) 80 (2) 79 (2) 60 (4)
Deceased brain-dead 85 (8) 85 (8) 85 (8) 42 (17)
Donor age group (yrs) 0.054
<20 72 (13) 72 (13) 72 (13) 72 (13)
20–40 87 (2) 86 (2) 86 (2) 60 (7)
>40 93 (3) 89 (4) 89 (4) 89 (4)
Donor sex 0.078
Male 89 (2) 86 (2) 86 (3) 73 (5)
Female 85 (4) 85 (4) 85 (4) 56 (10)

AZA: azathioprine, CSA: cyclosporine, MMF: mycophenolate mofetil, NA: not applicable, SEM: standard error of the mean, SRL: sirolimus, TAC: tacrolimus